Pilot study of a model-based approach to blood glucose control in very-low-birthweight neonates (2012)
Type of ContentJournal Article
PublisherUniversity of Canterbury. Mechanical Engineering
Background: Hyperglycemia often occurs in premature, very low birthweight infants (VLBW) due to immaturity of endogenous regulatory systems and the stress of their condition. Hyperglycemia in neonates has been linked to increased morbidities and mortality and occurs at increasing rates with decreasing birthweight. In this cohort, the emerging use of insulin to manage hyperglycemia has carried a significant risk of hypoglycemia. The efficacy of blood glucose control using a computer metabolic system model to determine insulin infusion rates was assessed in very-low-birth-weight infants. Methods: Initial short-term 24-hour trials were performed on 8 VLBW infants with hyperglycemia followed by long-term trials of several days performed on 22 infants. Median birthweight was 745g and 760g for short-term and long-term trial infants, and median gestational age at birth was 25.6 and 25.4 weeks respectively. Blood glucose control is compared to 21 retrospective patients from the same unit who received insulin infusions determined by sliding scales and clinician intuition. Results: Reduction in hyperglycemia towards the target glucose band was achieved safely in all cases during the short-term trials with no hypoglycemic episodes. Lower median blood glucose concentration was achieved during clinical implementation at 6.6 mmol/L (IQR: 5.5 - 8.2mmol/L, 1,003 measurements), compared to 8.0 mmol/L achieved in similar infants previously (p < 0.01). No significant difference in incidence of hypoglycemia during long-term trials was observed (p = 0.51). Percentage of blood glucose within the target range was increased by 83% compared to the retrospective cohort (p < 0.01). Conclusions: A computer model that accurately captures the dynamics of neonatal metabolism can provide safe and effective blood glucose control without increasing hypoglycemia.
CitationLe Compte, A.J., Lynn, A.M., Lin, J., Pretty, C.G., Shaw, G.M., Chase, J.G. (2012) Pilot study of a model-based approach to blood glucose control in very-low-birthweight neonates. BMC Pediatrics, 12(117).
This citation is automatically generated and may be unreliable. Use as a guide only.
ANZSRC Fields of Research40 - Engineering::4003 - Biomedical engineering::400303 - Biomechanical engineering
32 - Biomedical and clinical sciences::3202 - Clinical sciences::320208 - Endocrinology
Showing items related by title, author, creator and subject.
Altered blood glucose dynamics during and after anhepatic phase of liver transplantation: a model-based approach Homlok, J.; Chase, Geoff; Benyo, B.; Kovacs, K. (University of Canterbury. Mechanical Engineering, 2013)During liver transplantation (LT) the glucose metabolism is effected by a crucial disturbance. The blood glucose level is extremely hard to control by conventional clinical protocols during this phase. Model based ...
Le Compte, A.J.; Chase, Geoff; Russell, G.; Lynn, A.; Hann, C.E.; Shaw, Geoff; Wong, X-W.; Blakemore, A.; Lin, J. (University of Canterbury. Electrical and Computer EngineeringUniversity of Canterbury. Mechanical Engineering, 2011)BACKGROUND: Premature infants represent a significant proportion of the neonatal intensive care population. Blood glucose homeostasis in this group is often disturbed by immaturity of endogenous regulatory systems and the ...
Tight Glycemic Control in Critical Care - The leading role of insulin sensitivity and patient variability – A review and model-based analysis Chase, Geoff; Le Compte, A.J.; Suhaimi, F.; Shaw, Geoff; Lynn, A.; Lin, J.; Pretty, Christopher; Razak, N.N.; Parente, J.D.; Hann, C.E.; Preiser, J-C.; Desaive, T. (University of Canterbury. Electrical and Computer EngineeringUniversity of Canterbury. Mathematics and StatisticsUniversity of Canterbury. Mechanical Engineering, 2011)Tight glycemic control (TGC) has emerged as a major research focus in critical care due to its potential to simultaneously reduce both mortality and costs. However, repeating initial successful TGC trials that reduced ...